Since increased macrophage infiltration and complement activation have been linked to AMD disease progression, TSG-6 was administrated intravitreally to determine if it could have beneficial effect on retinal lesions in DKOrd8 [39]. The gene discussed is TNFAIP6; the disease is age-related macular degeneration.